News Headlines Article

Gilead’s new prescription drug can help patients fight Hepatitis C; But the price is sky-high
Benchmark Reporter

In 2014, the bio-tech giant released an even more effective drug, Harvoni, which had almost no side effects at all and a cure rate as high as 99%. The price tag was naturally higher – around $ 100,000.

The debate, whether the pharmaceutical companies are charging astronomical prices using an excuse that it is required for R&D, intensified when Amgen Inc., the Thousand Oaks Biotech giant, won the FDA approval on August 2015, of its cholesterol drug, Repatha and charged around $140,000 for it.